CStone Pharmaceuticals 2024 SR

The report highlights CStone Pharmaceuticals' commitment to developing innovative immuno-oncology and precision medicines, having successfully launched 4 drugs and secured 16 NDA approvals. In 2024, the company focused on improving drug accessibility, benefiting over 100 million people through insurance inclusions and patient assistance projects. Environmental efforts included a 15.13% reduction in total greenhouse gas emissions and a 9.80% decrease in electricity consumption. The company also maintained a strong focus on business ethics, product quality, and employee well-being, while actively participating in charitable initiatives like the Patient Assistance Program.

Company: CStone Pharmaceuticals

Sector: Health Care

Country: China

Year: 2024

Type: SR

Pages: 44

Back to company

CStone Pharmaceuticals

CStone Pharmaceuticals 2024 ESG Report

ESG Report

The report highlights CStone Pharmaceuticals' commitment to developing innovative immuno-oncology and precision medicines, having successfully launched 4 drugs and secured 16 NDA approvals. In 2024, the company focused on improving drug accessibility, benefiting over 100 million people through insurance inclusions and patient assistance projects. Environmental efforts included a 15.13% reduction in total greenhouse gas emissions and a 9.80% decrease in electricity consumption. The company also maintained a strong focus on business ethics, product quality, and employee well-being, while actively participating in charitable initiatives like the Patient Assistance Program.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2024

Reporting Period

Jan 1, 2024 - Dec 31, 2024

Fiscal Year

2024

Published

Mar 27, 2025

Type

Sustainability Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

Other Standards

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Energy Consumption

Water Consumption

Workplace Fatalities

Net Zero Target

Employees